Navigation Links
Bio-Solutions Corp. Expanding in Booming Diabetes Market
Date:8/29/2013

CORAL SPRINGS, Florida, August 29, 2013 /PRNewswire/ --

On Wednesday, Bio-Solutions Corp. (OTCQB: BISU) announced their Direct Response Infomercial and Marketing Campaign for its flagship product, Type2Defense. Over 30 million people suffer from Type 2 diabetes in the United States, according to seeking alpha. Additionally, it's forecasted that nearly 30 percent of the U.S.'s population will have diabetes by 2050, with most of that percentage facing Type 2.

United Healthcare predicts spending on diabetes will grow significantly over the next 10 years, estimating that the country will spend around $3.4 trillion on the disease. The total cost of diagnosed diabetes in 2012 was $245 billion, as stated by the American Diabetes Association. This was a 41 percent increase from 2007, when costs reached $174 billion.

Bio-Solutions' Type2 Defense is a powder blend of natural ingredients that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type II Diabetes. With the launch of Type 2 Defense's new infomercial and marketing campaign, BISU takes a significant step in their expansion across the U.S.

The partnership with Direct Response Marketing isn't the first step Bio-Solutions has taken in effort to expand, as they also recently announced they have begun a campaign on Lockerdome.com. Lockerdome.com is the premier destination on the internet for both professional and amateur athletes, with monthly traffic in excess of 14 million visitors. The Company's campaign on the website will allow young athletes with diabetes to interact with pro athletes also suffering from the disease.

For more recent news for BISU, please click on the following links:

http://finance.yahoo.com/news/bio-solutions-corporation-announces-campaign-113000206.html

http://finance.yahoo.com/news/bio-solutions-corporation-launches-type2defense-150000680.html

About Bio-Solutions Corp.

Bio-Solutions Corp. markets new and very effective organic products; our lead product is Type2 Defense™. Type2Defense™ a Diabetic Supplement Drink. Type2Defense™ is a new dietary supplement that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type 2 Diabetes. The Product's goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants. Consumers can find more information about the company and its products by going to http://www.BioSolutionsCorp.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes", "expects", "anticipates", "foresees", "forecasts", "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.

Investor Relations Contact
William Gallagher
+1-210-218-4475
info@biosolutionscorp.com

Contact:
FN Media Group, LLC
+1-954-345-0611
editor@financialnewsmedia.com



'/>"/>
SOURCE FN Media Group LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
2. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
3. SolutionStart Corp. Announces John Karagiannis as Vice President of Technology
4. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
5. ThermoGenesis Corp. To Announce Third Quarter Fiscal 2012 Results On May 10, 2012
6. Millennium Surgical Corp. Announces Sales Figures, Growth
7. Millennium Surgical Corp. Develops Online Sterilization Resource Center
8. Rittal Corp. Joins the HP ProActive Insight Architecture Alliance
9. Actinium Pharmaceuticals Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.
10. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2012 Financial Results on August 9, 2012
11. Online Pharmacy Domain Policy Changes Announced by ICANN Registrar Internet.bs Corp.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... VIEW, Calif. , June 23, 2016 ... a.m. CST on Thursday, July 7, 2016 , , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  , ... Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa ... The global pharmaceutical industry is witnessing an ...
(Date:6/23/2016)... 23, 2016 The vast majority of dialysis ... facility.  Treatments are usually 3 times a week, with ... including travel time, equipment preparation and wait time.  This ... grueling for patients who are elderly and frail.  Many ... and rehabilitation centers for some duration of time. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping ... fitness app. The fitness app plans to fix the two major problems leading the fitness ... size fits all type program , They don’t eliminate all the reasons people ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... , ... People across the U.S. are sharpening their pencils and honing their ... in which patients and their families pay tribute to a genetic counselor by nominating ... of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, ...
Breaking Medicine News(10 mins):